Inventor
PAYNE GILLIAN
US19 patents
⚠️ This page may combine multiple inventors who share the name “PAYNE GILLIAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
IMMUNOGEN INC
14 patentsUS9670279B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC26 citations98
US9133275B2Sep 15, 2015
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC45 citations98
US10752683B2Aug 25, 2020
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC13 citations94
US10301385B2May 28, 2019
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC8 citations92
US9670280B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC19 citations92
US9670278B2Jun 6, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC18 citations92
US9657100B2May 23, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC16 citations92
US9598490B2Mar 21, 2017
Folate receptor 1 antibodies and immunoconjugates and uses thereof
IMMUNOGEN INC18 citations92
US7202346B2Apr 10, 2007
Antibodies to non-shed Muc1 and Muc16, and uses thereof
IMMUNOGEN INC62 citations92
US7834155B2Nov 16, 2010
CA6 antigen-specific cytotoxic conjugate and methods of using the same
IMMUNOGEN INC13 citations91
US11135305B2Oct 5, 2021
Methods for increasing efficacy of FOLR1 cancer therapy
IMMUNOGEN INC9 citations83
US10603388B2Mar 31, 2020
Methods for formulating antibody drug conjugate compositions
IMMUNOGEN INC5 citations64
US9125896B2Sep 8, 2015
EGFR-binding molecules and immunoconjugates thereof
IMMUNOGEN INC3 citations62
US9822183B2Nov 21, 2017
CA6 antigen-specific cytotoxic conjugate and methods of using the same
IMMUNOGEN INC0 citations50